140 related articles for article (PubMed ID: 33648758)
1. Differences in tumour heterogeneity based on dynamic contrast-enhanced MRI between tumour and peritumoural stroma for predicting Ki-67 status of invasive ductal carcinoma.
He X; Zhou J; Ye S; Cheng Q; Miao H; Xu N; Li J; Pan Z; Cheng J; Wang M
Clin Radiol; 2021 Jun; 76(6):470.e13-470.e22. PubMed ID: 33648758
[TBL] [Abstract][Full Text] [Related]
2. DCE-MRI texture analysis with tumor subregion partitioning for predicting Ki-67 status of estrogen receptor-positive breast cancers.
Fan M; Cheng H; Zhang P; Gao X; Zhang J; Shao G; Li L
J Magn Reson Imaging; 2018 Jul; 48(1):237-247. PubMed ID: 29219225
[TBL] [Abstract][Full Text] [Related]
3. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
[TBL] [Abstract][Full Text] [Related]
4. MRI texture analysis in differentiating luminal A and luminal B breast cancer molecular subtypes - a feasibility study.
Holli-Helenius K; Salminen A; Rinta-Kiikka I; Koskivuo I; Brück N; Boström P; Parkkola R
BMC Med Imaging; 2017 Dec; 17(1):69. PubMed ID: 29284425
[TBL] [Abstract][Full Text] [Related]
5. Integration of dynamic contrast-enhanced magnetic resonance imaging and T2-weighted imaging radiomic features by a canonical correlation analysis-based feature fusion method to predict histological grade in ductal breast carcinoma.
Fan M; Liu Z; Xie S; Xu M; Wang S; Gao X; Li L
Phys Med Biol; 2019 Oct; 64(21):215001. PubMed ID: 31470420
[TBL] [Abstract][Full Text] [Related]
6. Time-to-enhancement at ultrafast breast DCE-MRI: potential imaging biomarker of tumour aggressiveness.
Shin SU; Cho N; Kim SY; Lee SH; Chang JM; Moon WK
Eur Radiol; 2020 Jul; 30(7):4058-4068. PubMed ID: 32144456
[TBL] [Abstract][Full Text] [Related]
7. Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer.
Nagasaka K; Satake H; Ishigaki S; Kawai H; Naganawa S
Breast Cancer; 2019 Jan; 26(1):113-124. PubMed ID: 30069785
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.
Shin JK; Kim JY
J Magn Reson Imaging; 2017 Jan; 45(1):94-102. PubMed ID: 27313102
[TBL] [Abstract][Full Text] [Related]
9. Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.
Ryu JK; Rhee SJ; Song JY; Cho SH; Jahng GH
J Appl Clin Med Phys; 2016 Sep; 17(5):377-390. PubMed ID: 27685105
[TBL] [Abstract][Full Text] [Related]
10. Is there different correlation with prognostic factors between "non-mass" and "mass" type invasive ductal breast cancers?
Jiang L; Zhou Y; Wang Z; Lu X; Chen M; Zhou C
Eur J Radiol; 2013 Sep; 82(9):1404-9. PubMed ID: 23540946
[TBL] [Abstract][Full Text] [Related]
11. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
[TBL] [Abstract][Full Text] [Related]
12. Invasive ductal breast cancer: preoperative predict Ki-67 index based on radiomics of ADC maps.
Zhang Y; Zhu Y; Zhang K; Liu Y; Cui J; Tao J; Wang Y; Wang S
Radiol Med; 2020 Feb; 125(2):109-116. PubMed ID: 31696388
[TBL] [Abstract][Full Text] [Related]
13. Utility of synthetic MRI in predicting the Ki-67 status of oestrogen receptor-positive breast cancer: a feasibility study.
Matsuda M; Kido T; Tsuda T; Okada K; Shiraishi Y; Suekuni H; Kamei Y; Kitazawa R; Mochizuki T
Clin Radiol; 2020 May; 75(5):398.e1-398.e8. PubMed ID: 32019671
[TBL] [Abstract][Full Text] [Related]
14. Association among T2 signal intensity, necrosis, ADC and Ki-67 in estrogen receptor-positive and HER2-negative invasive ductal carcinoma.
Kim SY; Kim EK; Moon HJ; Yoon JH; Koo JS; Kim SG; Kim MJ
Magn Reson Imaging; 2018 Dec; 54():176-182. PubMed ID: 30172938
[TBL] [Abstract][Full Text] [Related]
15. Utility of apparent diffusion coefficient as an imaging biomarker for assessing the proliferative potential of invasive ductal breast cancer.
Zhuang Z; Zhang Q; Zhang D; Cheng F; Suo S; Geng X; Hua J; Xu J
Clin Radiol; 2018 May; 73(5):473-478. PubMed ID: 29273228
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction of lymphovascular invasion in invasive breast cancer with dynamic contrast-enhanced-MRI-based radiomics.
Liu Z; Feng B; Li C; Chen Y; Chen Q; Li X; Guan J; Chen X; Cui E; Li R; Li Z; Long W
J Magn Reson Imaging; 2019 Sep; 50(3):847-857. PubMed ID: 30773770
[TBL] [Abstract][Full Text] [Related]
17. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Quantitative MRI Using 3D-QALAS for Discriminating Immunohistochemical Status in Invasive Ductal Carcinoma of the Breast.
Amano M; Fujita S; Takei N; Sano K; Wada A; Sato K; Kikuta J; Kuwatsuru Y; Tachibana R; Sekine T; Horimoto Y; Aoki S
J Magn Reson Imaging; 2023 Dec; 58(6):1752-1759. PubMed ID: 36951614
[TBL] [Abstract][Full Text] [Related]
19. Quantification of breast tumor heterogeneity for ER status, HER2 status, and TN molecular subtype evaluation on DCE-MRI.
Chang RF; Chen HH; Chang YC; Huang CS; Chen JH; Lo CM
Magn Reson Imaging; 2016 Jul; 34(6):809-819. PubMed ID: 26968141
[TBL] [Abstract][Full Text] [Related]
20. Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers.
Trimboli RM; Codari M; Khouri Chalouhi K; Ioan I; Lo Bue G; Ottini A; Casolino D; Carbonaro LA; Sardanelli F
Radiol Med; 2018 Feb; 123(2):91-97. PubMed ID: 28948442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
